Nottingham Galway - National University of Ireland, Galway

Professor John Crown
John Crown
Professor Paul Goss
Paul Goss
12
Consultant Medical Oncologist St. Vincent’s University Hospital & Thomas
Baldwin Chair in Cancer Research Dublin City University, Ireland. Consultant
Medical Oncologist with St. Vincent’s University Hospital and St. Luke’s
Hospital in Dublin, Ireland. In November 2003, he was awarded the Thomas
Baldwin Research Chair in Translational Cancer Research from Dublin City
University and in December 2004 was awarded the Newman Clinical
Research Professorship in the School of Medicine of University College
Dublin. Professor Crown is a founding member and leader of many
organizations that include the Irish Clinical Oncology Research Group, the
Anglo-Celtic Oncology Group, the European Breast Cancer Dose Intensity
Study, and the Irish Society of Medical Oncology. His other memberships
include ASCO, AACR, and ESMO. Professor Crown chairs the Breast Committee
of the Irish Clinical Oncology Research Group (ICORG). Professor Crown
received his medical training at the University College Dublin and the State
University of New York. He received his postdoctoral training on both sides of
the Atlantic. Professor Crown went on to complete his fellowship training in
oncology at Mount Sinai Medical Centre and in haematology/oncology at
Memorial Sloan Kettering Cancer Centre. He served as assistant professor at
Cornell University Medical College before joining St. Vincent’s University
Hospital in 1993.
Professor Paul Goss was educated at the University of Witwatersrand in
Johannesburg, South Africa before pursuing postgraduate training in
oncology and a doctorate in hormonal mechanisms of breast cancer at the
University of London. He subsequently became Professor of Medicine at the
University of Toronto and Director of the Breast Cancer Research Program at
the Princess Margaret Hospital. In September 2004, Dr. Goss assumed a
position as Director of Breast Cancer Research and Avon Foundation Senior
Scholar at Massachusetts General Hospital Cancer Center and Professor of
Medicine, Harvard Medical School. Dr. Goss’ principal research interest has
been to explore the pivotal role of estrogen in the pathogenesis of breast
cancer. He chairs a multitude of international clinical trials. His recently
completed MA17 study of letrozole after tamoxifen led to FDA approval and
changed the practice of oncology worldwide. His translational laboratory
program focuses on tumor signatures and mechanisms of endocrine
resistance. Dr. Goss has published over 200 manuscripts, sits on numerous
international scientific committees and serves as ad hoc reviewer for many
scientific and medical journals.